Purpose: Autosomal dominant optic atrophy (ADOA) is a primary hereditary optic neuropathy leading to loss of visual acuity. The clinical disease is caused by homozygous null mutations in the OPA1 gene. Northern blots have shown that OPA1 is ubiquitously expressed. However, the fundamental pathology of ADOA is primary degeneration of retinal ganglion cells (RGC's) followed by ascending atrophy of the optic nerve. RGC is the first cell commitment made during the development of the retina. In order to understand the pathophysiology of ADOA, we aimed to (1) assess the expression pattern of OPA1 mRNA and protein during different stages of mouse prenatal and postnatal development and (2) assess if OPA1 expression is retained in adult human tissue...
purpose. To examine retinal ganglion cell (RGC) and axonal abnormalities in an ENU-induced mutant mo...
Autosomal dominant optic atrophy (ADOA) is a hereditary optic neuropathy characterized by bilateral ...
Heading: To identify pathogenic mutations in patients with ADOA, previously excluded for LHON mutati...
Purpose: Autosomal dominant optic atrophy (ADOA) is a primary hereditary optic neuropathy leading to...
PURPOSE: Autosomal dominant optic atrophy (ADOA) is characterized by primary degeneration of retina...
PURPOSE. Autosomal dominant optic atrophy is a hereditary disorder characterized by progressive loss...
PURPOSE: Mutations in the OA1 gene cause ocular albinism type 1 (OA1), an X-linked form of albinism ...
Autosomal dominant optic atrophy (ADOA) is a slowly progressive ocular disorder associated with reti...
Autosomal dominant optic atrophy (ADOA) is the most prevalent hereditary optic neuropathy resulting ...
International audienceDominant optic atrophy (DOA) is a rare progressive and irreversible blinding d...
Dominant optic atrophy (DOA) is the most common inherited optic neuropathy affecting one in every 12...
BACKGROUND: Autosomal dominant optic atrophy type 1 (DOA) is the most common form of hereditary opti...
International audienceThe OPA1 gene, encoding a dynamin-like mitochondrial GTPase, is involved in au...
Dominant optic atrophy (DOA) is mainly caused by OPA1 mutations and is characterized by the degenera...
Autosomal dominant optic atrophy (ADOA) is the most frequent hereditary optic neuropathy. Three loci...
purpose. To examine retinal ganglion cell (RGC) and axonal abnormalities in an ENU-induced mutant mo...
Autosomal dominant optic atrophy (ADOA) is a hereditary optic neuropathy characterized by bilateral ...
Heading: To identify pathogenic mutations in patients with ADOA, previously excluded for LHON mutati...
Purpose: Autosomal dominant optic atrophy (ADOA) is a primary hereditary optic neuropathy leading to...
PURPOSE: Autosomal dominant optic atrophy (ADOA) is characterized by primary degeneration of retina...
PURPOSE. Autosomal dominant optic atrophy is a hereditary disorder characterized by progressive loss...
PURPOSE: Mutations in the OA1 gene cause ocular albinism type 1 (OA1), an X-linked form of albinism ...
Autosomal dominant optic atrophy (ADOA) is a slowly progressive ocular disorder associated with reti...
Autosomal dominant optic atrophy (ADOA) is the most prevalent hereditary optic neuropathy resulting ...
International audienceDominant optic atrophy (DOA) is a rare progressive and irreversible blinding d...
Dominant optic atrophy (DOA) is the most common inherited optic neuropathy affecting one in every 12...
BACKGROUND: Autosomal dominant optic atrophy type 1 (DOA) is the most common form of hereditary opti...
International audienceThe OPA1 gene, encoding a dynamin-like mitochondrial GTPase, is involved in au...
Dominant optic atrophy (DOA) is mainly caused by OPA1 mutations and is characterized by the degenera...
Autosomal dominant optic atrophy (ADOA) is the most frequent hereditary optic neuropathy. Three loci...
purpose. To examine retinal ganglion cell (RGC) and axonal abnormalities in an ENU-induced mutant mo...
Autosomal dominant optic atrophy (ADOA) is a hereditary optic neuropathy characterized by bilateral ...
Heading: To identify pathogenic mutations in patients with ADOA, previously excluded for LHON mutati...